These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6433456)

  • 1. Review of the transmission of hepatitis by clotting factor concentrates.
    Tabor E
    Scand J Haematol Suppl; 1984; 40():303-8. PubMed ID: 6433456
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plasma concentrates of factor VIII. Where are we?].
    Vicente V
    Sangre (Barc); 1989 Feb; 34(1):1-3. PubMed ID: 2496481
    [No Abstract]   [Full Text] [Related]  

  • 3. [Post-transfusion hepatitis and its sequelae in the treatment of hemophilia].
    Schimpf K
    Behring Inst Mitt; 1983 Aug; (73):111-7. PubMed ID: 6433878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment for evidence of non A-non B hepatitis in patients given n-heptane-suspended heat-treated clotting factor concentrates.
    Carnelli V; Gomperts ED; Friedman A; Aledort L; Hilgartner M; Dietrich S; Fedor EJ
    Thromb Res; 1987 Jun; 46(6):827-34. PubMed ID: 3114910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological evidence that dry heating of clotting factor concentrates prevents transmission of non-A, non-B hepatitis.
    Skidmore SJ; Pasi KJ; Mawson SJ; Williams MD; Hill FG
    J Med Virol; 1990 Jan; 30(1):50-2. PubMed ID: 2106006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of hepatitis-B immunoglobulin to clotting factors.
    Smit Sibinga CT; Das PC; Nieweg HO
    Lancet; 1980 Sep; 2(8193):537. PubMed ID: 6105586
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of hemophilia in children].
    Stucchi C; Giovanniello A; Dozzi M; Careddu P; Carnelli V
    Pediatr Med Chir; 1989; 11(6):607-15. PubMed ID: 2517639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-A non-B hepatitis caused by transfusing American antihemophilic globulin (factor VIII) in patients with hemophilia].
    Zhang Z; Li YH; Li XF
    Zhonghua Nei Ke Za Zhi; 1988 Feb; 27(2):82-4, 134. PubMed ID: 3141119
    [No Abstract]   [Full Text] [Related]  

  • 9. Viral safety issues: plasma-derived factor VIII.
    Berntorp E
    Ann Hematol; 1994; 68 Suppl 3():S35-6. PubMed ID: 8180256
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention of transfusion-associated virus infections in hemophilic patients needing replacement therapy].
    Meili EO
    Beitr Infusionsther; 1989; 24():46-55. PubMed ID: 2481548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy-induced hepatitis risk in hemophilia patients].
    Schiller WG; Renger FG
    Z Arztl Fortbild (Jena); 1983; 77(19):807-10. PubMed ID: 6417919
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of hepatitis C virus infection in haemophiliacs.
    Barbara JA; Contreras M
    Lancet; 1990 Jul; 336(8706):62-3. PubMed ID: 1973252
    [No Abstract]   [Full Text] [Related]  

  • 13. Prothrombin complex concentrates for clinical use.
    Chandra S; Brummelhuis HG
    Vox Sang; 1981; 41(5-6):257-73. PubMed ID: 6798760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UK: Hemophiliac wins access to recombinant factor VIII.
    Gold J
    Can HIV AIDS Policy Law Rev; 2003 Dec; 8(3):62. PubMed ID: 15108666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short incubation non-A, non-B hepatitis transmitted by factor VIII concentrates in patients with congenital coagulation disorders: a preliminary report of an antigen/antibody system.
    Bamber M; Murray A; Kernoff PB; Thomas HC
    Med Lab Sci; 1981 Oct; 38(4):373-8. PubMed ID: 6799726
    [No Abstract]   [Full Text] [Related]  

  • 16. The safety of blood components and derivatives.
    Julius C; Westphal RG
    Hematol Oncol Clin North Am; 1992 Oct; 6(5):1057-77. PubMed ID: 1400072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clotting factor concentrates].
    Barthels M; Oldenburg J
    Hamostaseologie; 2008 Dec; 28(5):387-99. PubMed ID: 19132169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis, type B in haemophiliacs. Relation to the source of clotting factor concentrates.
    Holsteen V; Skinhoj P; Cohn J
    Scand J Haematol; 1977 Mar; 18(3):214-8. PubMed ID: 847395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of hepatitis-B immunoglobulin to clotting factor.
    Scaroni C; Cancellieri V; Carnelli V; Moroni GA; Angeli M
    Lancet; 1980 Sep; 2(8193):537-8. PubMed ID: 6105587
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute hepatitis non-A, non-B following administration of factor VIII concentrates.
    Norkrans G; Widell A; Teger-Nilsson AC; Kjellman H; Frösner G; Iwarson S
    Vox Sang; 1981 Sep; 41(3):129-33. PubMed ID: 6800131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.